[1]CHEN YP,CHAN ATC,LE QT,et al.Nasopharyngeal carcinoma[J].Lancet,2019,394(10192):64-80.
[2]PENG Z,WANG Y,FAN R,et al.Treatment of recurrent nasopharyngeal carcinoma:A sequential challenge[J].Cancers(Basel),2022,14(17):4111.
[3]CHANG ET,YE W,ZENG YX,et al.The evolving epidemiology of nasopharyngeal carcinoma[J].Cancer Epidemiol Biomarkers Prev,2021,30(6):1035-1047.
[4]LEE AW,MA BB,NG WT,et al.Management of nasopharyngeal carcinoma:Current practice and future perspective[J].J Clin Oncol,2015,33(29):3356-3364.
[5]WAN FZ,CHEN KH,SUN YC,et al.Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma[J].J Transl Med,2020,18(1):12.
[6]MENG S,ZHOU H,FENG Z,et al.CircRNA:functions and properties of a novel potential biomarker for cancer[J].Mol Cancer,2017,16(1):94.
[7]ZHOU WY,CAI ZR,LIU J,et al.Circular RNA:Metabolism,functions and interactions with proteins[J].Mol Cancer,2020,19(1):172.
[8]SHANG Q,YANG Z,JIA R,et al.The novel roles of circRNAs in human cancer[J].Mol Cancer,2019,18(1):6.
[9]ZHONG Y,DU Y,YANG X,et al.Circular RNAs function as ceRNAs to regulate and control human cancer progression[J].Mol Cancer,2018,17(1):79.
[10]HE SL,ZHAO X,YI SJ.CircAHNAK upregulates EIF2B5 expression to inhibit the progression of ovarian cancer by modulating the JAK2/STAT3 signaling pathway[J].Carcinogenesis,2022,43(10):941-955.
[11]LIAO C,LIU H,LUO X.The emerging roles of exosomal miRNAs in nasopharyngeal carcinoma[J].Am J Cancer Res,2021,11(6):2508-2520.
[12]SIAK PY,KHOO AS,LEONG CO,et al.Current status and future perspectives about molecular biomarkers of nasopharyngeal carcinoma[J].Cancers(Basel),2021,13(14):3490.
[13]LI X,YANG L,CHEN LL.The biogenesis,functions,and challenges of circular RNAs[J].Mol Cell,2018,71(3):428-442.
[14]MO Y,WANG Y,ZHANG S,et al.Circular RNA circRNF13 inhibits proliferation and metastasis of nasopharyngeal carcinoma via SUMO2[J].Mol Cancer,2021,20(1):112.
[15]ZHAO M,WANG Y,TAN F,et al.Circular RNA circCCNB1 inhibits the migration and invasion of nasopharyngeal carcinoma through binding and stabilizing TJP1 mRNA[J].Sci China Life Sci,2022,65(11):2233-2247.
[16]HU X,LI J,FU M,et al.The JAK/STAT signaling pathway:from bench to clinic[J].Signal Transduct Target Ther,2021,6(1):402.
[17]TZENG HT,CHYUAN IT,LAI JH.Targeting the JAK-STAT pathway in autoimmune diseases and cancers:A focus on molecular mechanisms and therapeutic potential[J].Biochem Pharmacol,2021,193:114760.
[18]逄明杰,胡文婷,王宁宁,等.JAK2和STAT3在鼻咽癌中的表达及其与临床病理特征和预后的关系[J].现代肿瘤医学,2018,26(23):3743-3748.
PANG MJ,HU WT,WANG NN,et al.Expression of JAK2 and STAT3 and its correlation with prognosis in nasopharyngeal carcinoma[J].Modern Oncology,2018,26(23):3743-3748.
[19]HUYNH J,ETEMADI N,HOLLANDE F,et al.The JAK/STAT3 axis:A comprehensive drug target for solid malignancies[J].Semin Cancer Biol,2017,45:13-22.
[20]JAKIEWICZ A,DOMORADZKI T,PAJAK B.Targeting the JAK2/STAT3 pathway-Can we compare it to the two faces of the god janus[J].Int J Mol Sci,2020,21(21):8261.
[21]LIU H,DU T,LI C,et al.STAT3 phosphorylation in central leptin resistance[J].Nutr Metab(Lond),2021,18(1):39.
[22]DONGRE A,WEINBERG RA.New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer[J].Nat Rev Mol Cell Biol,2019,20(2):69-84.